|
00904003620
|
6505-01-281-9690
|
Loperamide Hydrochloride Oral So |
Major Pharmaceuticals Inc
|
|
Quote
|
|
50383061804
|
6505-01-281-9690
|
Loperamide Hydrochloride Oral So |
Hi-tech Pharmacal Co., Inc.
|
|
Quote
|
|
NDC50383-0618-04
|
6505-01-281-9690
|
Loperamide Hydrochloride Oral So |
Hi-tech Pharmacal Co., Inc.
|
|
Quote
|
|
NDC00904-0036-20
|
6505-01-281-9690
|
Loperamide Hydrochloride Oral So |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC50458-0410-04
|
6505-01-281-9690
|
Loperamide Hydrochloride Oral So |
Janssen Pharmaceutica Inc
|
|
Quote
|
|
29304
|
6505-01-281-9690
|
Loperamide Hydrochloride Oral So |
Ferrell and Co
|
|
Quote
|
|
NDC50580-0293-04
|
6505-01-281-9690
|
Loperamide Hydrochloride Oral So |
Mcneil Consumer Products Co
|
|
Quote
|
|
PEPCID
|
6505-01-282-1180
|
Famotidine Injection |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
PEPCID INJECTION
|
6505-01-282-1180
|
Famotidine Injection |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
PEPCID IV
|
6505-01-282-1180
|
Famotidine Injection |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
3541
|
6505-01-282-1180
|
Famotidine Injection |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00006-3541-14
|
6505-01-282-1180
|
Famotidine Injection |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NASAL
|
6505-01-282-1826
|
Sodium Chloride Nasal Solution |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC00024-1315-01
|
6505-01-282-1826
|
Sodium Chloride Nasal Solution |
Sanofi-synthelabo Inc
|
|
Quote
|
|
TAGAMENT
|
6505-01-282-2970
|
Cimetidine Hydrochloride Injecti |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
TAGAMENT INJECTION
|
6505-01-282-2970
|
Cimetidine Hydrochloride Injecti |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00108-5022-16
|
6505-01-282-2970
|
Cimetidine Hydrochloride Injecti |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
0057600
|
6505-01-282-3701
|
Meclizine Hydrochloride Tablets |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC51079-0089-20
|
6505-01-282-3701
|
Meclizine Hydrochloride Tablets |
Mylan Institutional Inc.
|
|
Quote
|
|
60685-9
|
6505-01-282-3702
|
Magnesia And Alumina Oral Suspen |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC51079-0338-10
|
6505-01-282-3702
|
Magnesia And Alumina Oral Suspen |
Mylan Institutional Inc.
|
|
Quote
|
|
PRINIVIL
|
6505-01-282-6327
|
Usp Lisinopril Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
ZESTRIL TABLETS
|
6505-01-282-6327
|
Usp Lisinopril Tablets |
Astrazeneca Lp
|
|
Quote
|
|
NDC00006-0207-58
|
6505-01-282-6327
|
Usp Lisinopril Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00310-0132-11
|
6505-01-282-6327
|
Usp Lisinopril Tablets |
Astrazeneca Lp
|
|
Quote
|
|
NDC00143-1268-01
|
6505-01-282-6327
|
Usp Lisinopril Tablets |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
NDC00378-2075-01
|
6505-01-282-6327
|
Usp Lisinopril Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
ZESTRIL
|
6505-01-282-6327
|
Usp Lisinopril Tablets |
Astrazeneca Lp
|
|
Quote
|
|
NDC00143-9713-01
|
6505-01-282-6327
|
Usp Lisinopril Tablets |
West-ward Pharmaceuticals Corp.
|
|
Quote
|
|
NDC00185-0620-01
|
6505-01-282-6327
|
Usp Lisinopril Tablets |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00574-0120-08
|
6505-01-282-8880
|
Suspension Activated Charcoal |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
NDC00574-0120-08
|
6505-01-282-8880
|
Suspension Activated Charcoal |
Veterans Health
|
|
Quote
|
|
ACTIDOSE
|
6505-01-282-8880
|
Suspension Activated Charcoal |
Paddock Laboratories Inc.
|
|
Quote
|
|
NDC00574-0120-08
|
6505-01-282-8880
|
Suspension Activated Charcoal |
Paddock Laboratories Inc.
|
|
Quote
|
|
NDC00574-0120-08
|
6505-01-282-8880
|
Suspension Activated Charcoal |
Cardinal Health 200, Llc
|
|
Quote
|
|
95-0441
|
6505-01-282-8880
|
Suspension Activated Charcoal |
Defense Logistics Agency
|
|
Quote
|
|
NDC00574-0121-08
|
6505-01-282-8880
|
Suspension Activated Charcoal |
Perrigo Company
|
|
Quote
|
|
NDC00004-0028-28
|
6505-01-282-9716
|
Naproxen Oral Suspension |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00054-3630-63
|
6505-01-282-9716
|
Naproxen Oral Suspension |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
TIMENTIN
|
6505-01-283-0066
|
Ticarcillin And Clavulanic Acid |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00029-6571-40
|
6505-01-283-0066
|
Ticarcillin And Clavulanic Acid |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00029-6571-40
|
6505-01-283-0066
|
Ticarcillin And Clavulanic Acid |
Cardinal Health 100 Inc
|
|
Quote
|
|
44143
|
6505-01-283-0164
|
Niacin Extended-release Capsules |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00182-0811-10
|
6505-01-283-0164
|
Niacin Extended-release Capsules |
Goldline Laboratories Inc.
|
|
Quote
|
|
411-1102
|
6505-01-283-0164
|
Niacin Extended-release Capsules |
Schein Henry Inc
|
|
Quote
|
|
NDC00536-4074-10
|
6505-01-283-0164
|
Niacin Extended-release Capsules |
Watson Labs Inc
|
|
Quote
|
|
411-1102
|
6505-01-283-0164
|
Niacin Extended-release Capsules |
Henry Schein, Inc.
|
|
Quote
|
|
ROCEPHIN
|
6505-01-283-0415
|
Usp Ceftriaxone Sodium |
Roche Medical Electronics Inc Sub Of
|
|
Quote
|
|
74516
|
6505-01-283-0415
|
Usp Ceftriaxone Sodium |
Roche Medical Electronics Inc Sub Of
|
|
Quote
|
|
NDC00004-1971-01
|
6505-01-283-0415
|
Usp Ceftriaxone Sodium |
Roche Medical Electronics Inc Sub Of
|
|
Quote
|
|
F90DO49
|
6505-01-283-1050
|
Contact Lens Disinfecting Soluti |
Air Force Medical Logistics Office
|
|
Quote
|
|
AOSEPT
|
6505-01-283-1050
|
Contact Lens Disinfecting Soluti |
Ciba Vision Corp
|
|
Quote
|
|
AOSEPT SOLUTION
|
6505-01-283-1050
|
Contact Lens Disinfecting Soluti |
Ciba Vision Corp
|
|
Quote
|
|
60500
|
6505-01-283-1050
|
Contact Lens Disinfecting Soluti |
Ciba Vision Corp
|
|
Quote
|
|
88A160500
|
6505-01-283-1050
|
Contact Lens Disinfecting Soluti |
Ciba Vision Corp
|
|
Quote
|
|
NDC47113-6050-00
|
6505-01-283-1050
|
Contact Lens Disinfecting Soluti |
Ciba Vision Corp
|
|
Quote
|
|
47113-60500
|
6505-01-283-1050
|
Contact Lens Disinfecting Soluti |
American Optical Co
|
|
Quote
|
|
KY LUBE JELLY
|
6505-01-283-1331
|
Surgical Lubricant |
General Medical Corp
|
|
Quote
|
|
K-Y JELLY
|
6505-01-283-1331
|
Surgical Lubricant |
Johnson & Johnson Sales And
|
|
Quote
|
|
171911
|
6505-01-283-1331
|
Surgical Lubricant |
General Medical Corp
|
|
Quote
|
|
NDC00137-8919-01
|
6505-01-283-1331
|
Surgical Lubricant |
Johnson & Johnson Sales And
|
|
Quote
|
|
8919
|
6505-01-283-1331
|
Surgical Lubricant |
Johnson & Johnson Sales And
|
|
Quote
|
|
NDC51079-0226-32
|
6505-01-283-2364
|
Usp Aluminum Hydroxide Gel |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00536-3919-50
|
6505-01-283-2721
|
Usp Hydrochlorothiazide Tablets |
Blair Industries Inc.
|
|
Quote
|
|
063909
|
6505-01-283-2722
|
Usp Lorazepam Tablets |
Sunoco Inc.
|
|
Quote
|
|
29875
|
6505-01-283-2722
|
Usp Lorazepam Tablets |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00003-0298-75
|
6505-01-283-2722
|
Usp Lorazepam Tablets |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00536-3959-10
|
6505-01-283-2722
|
Usp Lorazepam Tablets |
Rugby Group Inc
|
|
Quote
|
|
16130
|
6505-01-283-3658
|
Sulfamethoxazole And Trimethopri |
Astellas Pharma Us, Inc.
|
|
Quote
|
|
NDC00469-1610-50
|
6505-01-283-3658
|
Sulfamethoxazole And Trimethopri |
Astellas Pharma Us, Inc.
|
|
Quote
|
|
NDC00641-2766-41
|
6505-01-283-3658
|
Sulfamethoxazole And Trimethopri |
Elkins-sinn Inc
|
|
Quote
|
|
VANCOCIN
|
6505-01-283-3663
|
Sterile Vancomycin Hydrochloride |
Hospira, Inc.
|
|
Quote
|
|
VANCOCIN ADD-VANTAGE
|
6505-01-283-3663
|
Sterile Vancomycin Hydrochloride |
Hospira, Inc.
|
|
Quote
|
|
NDC00409-6535-01
|
6505-01-283-3663
|
Sterile Vancomycin Hydrochloride |
Hospira, Inc.
|
|
Quote
|
|
NDC66479-0542-10
|
6505-01-283-3664
|
Morphine Sulfate Extended-releas |
Xanodyne Pharmaceuticals Inc.
|
|
Quote
|
|
NDC59011-0262-10
|
6505-01-283-3664
|
Morphine Sulfate Extended-releas |
Purdue Pharma L.p.
|
|
Quote
|
|
RL-100
|
6505-01-283-5257
|
Modified Purified Water |
Laboratory Supply Co Inc
|
|
Quote
|
|
NDC00904-5168-38
|
6505-01-283-7955
|
Ophthalmic Lubricant |
Cardinal Health 100 Inc
|
|
Quote
|
|
NAPROSYN TABLETS
|
6505-01-284-0271
|
Usp Naproxen Tablets |
Syntex Laboratories Inc
|
|
Quote
|
|
NDC18393-0272-02
|
6505-01-284-0271
|
Usp Naproxen Tablets |
Syntex Laboratories Inc
|
|
Quote
|
|
1192
|
6505-01-284-0272
|
Lidocaine Hydrochloride Injectio |
International Medication Systems,
|
|
Quote
|
|
NDC00548-1192-00
|
6505-01-284-0272
|
Lidocaine Hydrochloride Injectio |
International Medication Systems,
|
|
Quote
|
|
NDC00486-1125-05
|
6505-01-284-1136
|
Ta Monobasic Potassium Phosphate |
Beach Products Inc
|
|
Quote
|
